Accelerated Biosciences Announces License of its Human Trophoblast Stem Cells (hTSC) to Agathos Biologics for Development of Ethically Sourced Research and Biomanufacturing Platforms

By WebmasterJune 5, 2024December 12th, 2024No Comments

Accelerated Biosciences Announces License of its Human Trophoblast Stem Cells (hTSC) to Agathos Biologics for Development of Ethically Sourced Research and Biomanufacturing Platforms

See more here

Previous PostIVIEW Therapeutics Inc. Announces Dosing of First Patient in Phase 1/2 Clinical Trial of IVW-1001 for Dry Eye Disease
Next PostAccelerated Biosciences and Spanios Partner to Advance Therapeutic Design Across Solid Tumor Cancers

Accelerated Biosciences Announces License of its Human Trophoblast Stem Cells (hTSC) to Agathos Biologics for Development of Ethically Sourced Research and Biomanufacturing Platforms

SEARCH

TOPICS

ARCHIVES

RECENT POSTS

Previous PostIVIEW Therapeutics Inc. Announces Dosing of First Patient in Phase 1/2 Clinical Trial of IVW-1001 for Dry Eye Disease

Next PostAccelerated Biosciences and Spanios Partner to Advance Therapeutic Design Across Solid Tumor Cancers